Official SEC submissions

Chemomab Therapeutics SEC Filings

Direct answer

Chemomab Therapeutics's latest SEC filing is 4.

It was filed on September 1, 2026, and 40 recent filings are available.

Each row links directly to the SEC document and filing index.

Official SEC EDGAR submissions

Get free Chemomab Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

Insider transaction

Filed: 2026-09-01

Report date: 2026-08-27

Open SEC document View filing index

6-K

Current report

Filed: 2026-08-19

Report date: 2026-06-30

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2026-07-08

Report date: 2026-07-08

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2026-06-02

Report date: 2026-06-02

6-K

Open SEC document View filing index

Insider transaction

Filed: 2026-06-01

Report date: 2026-05-29

Open SEC document View filing index

6-K

Current report

Filed: 2026-05-14

Report date: 2026-05-14

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2026-05-06

Report date: 2026-05-06

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2026-04-28

Report date: 2026-04-28

6-K

Open SEC document View filing index

20-F

Periodic report

Filed: 2026-03-23

Report date: 2025-12-31

20-F

Open SEC document View filing index

6-K

Current report

Filed: 2026-03-20

Report date: 2026-03-20

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2026-03-19

Report date: 2026-03-19

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2025-11-21

Report date: 2025-11-21

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2025-08-22

Report date: 2025-08-22

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2025-08-14

Report date: 2025-06-30

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2025-07-25

Report date: 2025-07-25

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2025-07-01

Report date: 2025-07-01

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2025-05-27

Report date: 2025-05-27

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2025-05-15

Report date: 2025-05-15

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2025-04-15

Report date: 2025-04-15

6-K

Open SEC document View filing index

20-F

Periodic report

Filed: 2025-04-04

Report date: 2024-12-31

20-F

Open SEC document View filing index

6-K

Current report

Filed: 2025-03-27

Report date: 2025-03-27

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2025-03-20

Report date: 2025-03-20

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2025-03-03

Report date: 2025-03-03

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2025-02-19

Report date: 2025-02-19

6-K

Open SEC document View filing index

SC 13D/A

Ownership report

Filed: 2024-11-29

SC 13D/A

Open SEC document View filing index

SC 13G

Ownership report

Filed: 2024-11-21

SCHEDULE 13G

Open SEC document View filing index

6-K

Current report

Filed: 2024-11-18

Report date: 2024-11-18

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2024-11-14

Report date: 2024-11-14

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2024-10-11

Report date: 2024-10-11

6-K

Open SEC document View filing index

SC 13D/A

Ownership report

Filed: 2024-09-16

AMENDMENT NO. 4

Open SEC document View filing index

144

Planned securities sale

Filed: 2024-09-12

Open SEC document View filing index

6-K

Current report

Filed: 2024-08-21

Report date: 2024-06-30

6-K

Open SEC document View filing index

SC 13G

Ownership report

Filed: 2024-08-20

SC 13G

Open SEC document View filing index

6-K

Current report

Filed: 2024-07-25

Report date: 2024-07-25

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2024-06-12

Report date: 2024-06-12

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2024-05-09

Report date: 2024-05-09

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2024-05-08

Report date: 2024-05-08

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2024-05-03

Report date: 2024-05-03

6-K

Open SEC document View filing index

20-F

Periodic report

Filed: 2024-03-28

Report date: 2023-12-31

20-F

Open SEC document View filing index

SC 13D/A

Ownership report

Filed: 2024-03-11

AMENDMENT NO. 3

Open SEC document View filing index

Verified data

Recent filing categories: 5
Recent filings: 40
SEC CIK: 0001534248
Latest filing date: September 1, 2026

Explore related company data

View the Chemomab Therapeutics company profile View Chemomab Therapeutics annual financials